Kasia Lipska, MD, MHS

All posts by Kasia Lipska, MD, MHS

August 12th, 2014

What Can We Really Deduce from ACCORD?

For Kasia Lipska, post hoc analyses of intensive glucose lowering in the ACCORD trial require greater scrutiny.

October 22nd, 2013

Are Sulfonylureas Dangerous?

Endocrinologist Kasia Lipska shares her thoughts about a presentation by Craig Currie at this year’s annual meeting of the European Association for the Study of Diabetes.

July 9th, 2013

Look AHEAD: More Questions Than Answers

Reflecting on the LOOK AHEAD trial, an endocrinologist asks some important questions: Should we hold lifestyle interventions to the same high standards of scrutiny as pharmacological interventions? Don’t we already have enough evidence about the impact of lifestyle interventions to implement them in care?

April 2nd, 2013

Intensive Glucose Control and ESRD – Strongest Evidence?

Kasia Lipska unpacks a report in Kidney International that claims to provide “the strongest evidence yet” of a protective effect of intensive glucose lowering against end-stage renal disease in type 2 diabetes.